Daniel D. Burgess - Insider Trading & Ownership

Location
C/O Hollis Eden Pharmaceuticals, 4435 Eastgate Mall Ste.400, San Diego, CA
Summary
The estimated net worth of Daniel D. Burgess is at least $204K dollars as of June 18, 2025. Daniel D. Burgess is the Director of Arbutus Biopharma Corp and owns shares of Arbutus Biopharma Corp (ABUS) stock worth about $188K. Daniel D. Burgess is the Director of Nabriva Therapeutics plc and owns shares of Nabriva Therapeutics plc stock worth about $15.6K.
Signature
/s/ Shane Ward, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Daniel D. Burgess

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ABUS Arbutus Biopharma Corp Director $188K May 23, 2024
NBRVF Nabriva Therapeutics plc Director $15.6K Aug 2, 2022
CDTX Cidara Therapeutics, Inc. Director Jun 18, 2025

Insider Transactions Reported by Daniel D. Burgess:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.